SCHEMBL6636740

SCHEMBL6636740

Cn1c(C=Cc2ccc(C#N)cc2)cc2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 1/20 0.61
MAOB P27338 2/20 0.54
TRPA1 O75762 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
NR1H3 Q13133 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
LMNA P02545 1/20 0.38
ADORA2A P29274 1/20 0.38
KMT2A Q03164 2/20 0.37
ENPP3 O14638 1/20 0.36
FBP1 P09467 2/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6636737 1.00 ALB (0.61) ALBMAOBTRPA1GRIN2DGRIN3B
SCHEMBL2604944 0.88 GRIN2D (0.49) ALBMAOBGRIN2DGRIN3BGRIN1
SCHEMBL2604894 0.83 MAOB (0.51) ALBMAOBGRIN2DGRIN3BGRIN1
SCHEMBL2604869 0.78 MAPT (0.48) ALBMAOBGRIN2DGRIN3BGRIN1
SCHEMBL16052706 0.77 ALB (0.51) ALBGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL16065502 0.77 ALB (0.51) ALBGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6270975 0.76 ALB (1.00) ALBMAOBTRPA1GRIN2DGRIN3B
SCHEMBL6262748 0.76 ALB (1.00) ALBMAOBTRPA1GRIN2DGRIN3B
SCHEMBL6274908 0.74 ALB (0.78) ALBTRPA1GRIN2DGRIN3BGRIN1
SCHEMBL6274906 0.74 ALB (0.78) ALBTRPA1GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
EP-1100795-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM ZENTRALE GMBH (DE) 2001-05-23 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed
WO-2000008014-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-02-17 WO disclosed